SNES
Get informed when a big investor buys or sells
+ FollowUndervalued by 203.8% based on the discounted cash flow analysis.
| Market cap | $7.42 Million |
|---|---|
| Enterprise Value | $3.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.95 |
| Beta | 0.29 |
| Outstanding Shares | 5,263,717 |
| P/E Ratio | -0.74 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 1.37 |
| Enterprise Value to Revenue | 1.47 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | 0.34 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 11.81%▼ 3.45% |
|---|---|
| Total Invested | $1.01M▼ 40.45% |
| Investors Holding | 15▼ 5.00% |
No data
SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in r...